Cancer patients are living longer. The sequelae of cancer treatment and the role of comorbid
conditions present before the diagnosis, such as CKD, have been increasingly recognized …

Aim Accurate evaluation of glomerular filtration rate (GFR) is crucial in Oncology as drug
eligibility and dosing depend on estimates of GFR. However, there are no clear guidelines …

A precise and efficient method for estimating kidney function in cancer patients is important
to determine their eligibility for clinical trials and surgery and to allow for appropriate dose …

Current guidelines recommend estimating glomerular filtration rate (eGFR) using creatinine
(eGFRcr) with the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation …

Important oncological management decisions rely on kidney function assessed by serum
creatinine–based estimated glomerular filtration rate (eGFR). However, no large-scale …

A narrow therapeutic index is a characteristic feature of cytotoxic agents. Some of these
agents are almost entirely eliminated renally in unchanged active form. As a consequence …

Background: Renal impairment (RI) has been shown to be one major risk factor in a number
of diseases and is associated with a dismal clinical outcome. However, the influence of …

Assessment of kidney function in oncology patients is a fundamental factor in profiling the
survival risk, determining the appropriate dose of chemotherapeutic drugs, and defining a …

Purpose: Management of patients with cancer, specifically carboplatin dosing, requires
accurate knowledge of glomerular filtration rate (GFR). Direct measurement of GFR is …

The prevalence of CKD may be higher in patients with cancer than in those without due to
the addition of cancer-specific risk factors to those already present for CKD. In this review …